Overview
Clinical Benefits
- Superior weight loss
- Blood sugar control
- Reduced appetite
- Improved metabolic markers
Administration
Subcutaneous injection — abdomen, thigh, or upper arm
Drug class: glp1 gip dual agonist
Clinical Dosing
Typical dosage
2.5mg starting, titrate up to 15mg
Starting dose
2.5mg
Cadence
Once weekly
Full titration schedule
| Phase | Dose |
|---|---|
| Weeks 1-4 | 2.5mg once weekly |
| Weeks 5-8 | 5mg once weekly |
| Weeks 9-12 | 7.5mg once weekly |
| Weeks 13-16 | 10mg once weekly |
| Weeks 17+ | 12.5-15mg once weekly (maintenance) |
Safety Profile
Side effects
- • Nausea (most common at dose increases)
- • Diarrhea
- • Vomiting
- • Decreased appetite
Contraindications
- • Medullary thyroid carcinoma
- • MEN 2 syndrome
Do not combine with
Frequently asked questions
Tirzepatide is most commonly researched for: Superior weight loss, Blood sugar control, Reduced appetite, Improved metabolic markers.
Ready to build a protocol with Tirzepatide?
LIA, our clinical reasoning engine, will build a personalized protocol — dosing, cadence, cycling, and safety checks — tailored to your goals and intake.
You’ll be asked to sign in first. Free tier includes the chat preview.
Information on this page is for educational purposes only and is not medical advice. Peptides should only be used under the supervision of a qualified healthcare provider.